Kymab
ID: 5643820Kymab is a biopharmecutical company developing human antibody based therapies founded in 2010.
4
Funding Rounds
$179.4m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Kymab has raised a total of $139.4m in funding over 4 rounds.
Key Insights:
- Kymab , January 2017: $9m
- Kymab Series C round, November 2016: $100m
- Kymab Series A round: $30.4m
- Kymab Series B round May 2014: $40m
Industries
Kymab is active in the following industries: